Phase 4 Deep Vein Thrombosis Clinical Trials
6 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–6 of 6 trials
Recruiting
Phase 4
inDividual, Targeted thrombosIS Prophylaxis Versus the Standard 'One Size Fits All' Approach in Patients Undergoing Total hIp or Total kNee replaCemenT
Venous ThromboembolismPulmonary EmbolismDeep Vein Thrombosis+1 more
Leiden University Medical Center10,078 enrolled10 locationsNCT06581965
Recruiting
Phase 4
Secondary Prevention of VTE in Patients With Cancer and Catheter-Related Upper Extremity Deep Vein Thrombosis
CancerVenous ThromboembolismUpper Extremity Deep Vein Thrombosis+1 more
Ottawa Hospital Research Institute330 enrolled1 locationNCT06603870
Recruiting
Phase 4
Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD)
SurgeryDeep Vein Thrombosis (DVT)Trauma+1 more
Oregon Health and Science University606 enrolled1 locationNCT02342444
Terminated
Phase 4
Enoxaparin compared to Warfarin for the treatment of calf vein blood clots
Calf Deep Vein Thrombosis
University of New South Wales86 enrolled1 locationACTRN12610000806066
Completed
Phase 3Phase 4
Assessment of microbleeding after prophylaxis with enoxaparin or rivaroxaban against venous thromboembolic disease following hip and knee surgery
Prevention and treatment of venous thromboembolism (VTE); comprising deep vein thrombosis (DVT) and pulmonary embolism (PE) after hip and knee arthroplasty.
Launceston General Hospital1,060 enrolled1 locationACTRN12609000762257
Completed
Phase 4
Individualised versus conventional enoxaparin dosing: a randomised controlled trial
Atrial FibrillationPulmonary EmbolismAcute Coronary Syndrome+1 more
School of Pharmacy140 enrolled2 locationsACTRN12608000573358